SCHEMBL30927042

SCHEMBL30927042

COc1ccc(NC(=O)c2ccccc2NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.64
KMT2A Q03164 2/20 0.64
ALDH1A1 P00352 1/20 0.64
MAPK1 P28482 1/20 0.64
SLC20A2 Q08357 1/20 0.63
SLC20A1 Q8WUM9 1/20 0.63
RXFP1 Q9HBX9 9/20 0.63
GAA P10253 1/20 0.61
AVPR2 P30518 1/20 0.56
GPR27 Q9NS67 1/20 0.56
NR1H4 Q96RI1 1/20 0.55
TOP1 P11387 1/20 0.54
PTGS2 P35354 1/20 0.54
SLC10A2 Q12908 1/20 0.54
SLC10A1 Q14973 1/20 0.54
SLC10A6 Q3KNW5 1/20 0.54
USP2 O75604 1/20 0.53
USP8 P40818 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27179805 1.00 MEN1 (0.64) MEN1KMT2AALDH1A1MAPK1SLC20A2
SCHEMBL23200355 0.85 MEN1 (0.67) MEN1KMT2AALDH1A1SLC20A2SLC20A1
SCHEMBL30926890 0.85 MEN1 (0.67) MEN1KMT2AALDH1A1SLC20A2SLC20A1
SCHEMBL30926577 0.85 MEN1 (0.76) MEN1KMT2ASLC20A2SLC20A1RXFP1
SCHEMBL7128448 0.85 MEN1 (0.76) MEN1KMT2ASLC20A2SLC20A1RXFP1
SCHEMBL28665402 0.84 RXFP1 (0.80) RXFP1NR1H4TOP1PTGS2
SCHEMBL30926819 0.84 MEN1 (0.68) MEN1KMT2AALDH1A1MAPK1SLC20A2
SCHEMBL27181165 0.84 MEN1 (0.68) MEN1KMT2AALDH1A1MAPK1SLC20A2
SCHEMBL28454669 0.83 MEN1 (0.64) MEN1KMT2ASLC20A2SLC20A1RXFP1
SCHEMBL7120286 0.83 SLC20A2 (0.74) MEN1KMT2AALDH1A1SLC20A2SLC20A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS TEXAS CROP SCIENCE, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240099300-A1 SULFONAMIDE APYRASE INHIBITORS APEH, ARSA, DNPEP MEN1 4795/4885KMT2A 2544/4885ALDH1A1 1085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.